These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]
6. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT. Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544 [Abstract] [Full Text] [Related]
7. The management of patients with attention-deficit hyperactivity disorder by family practitioners. Eppright TD, Bradley S, Vogel SJ, Williamson HA. Mo Med; 1998 Mar; 95(3):118-22. PubMed ID: 9529896 [Abstract] [Full Text] [Related]
8. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C, Boidein F. Encephale; 2001 Mar; 27(5):435-43. PubMed ID: 11760693 [Abstract] [Full Text] [Related]
9. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203 [Abstract] [Full Text] [Related]
11. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?]. Hansen L, Thomsen PH. Ugeskr Laeger; 2005 Nov 28; 167(48):4555-9. PubMed ID: 16324436 [Abstract] [Full Text] [Related]
16. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Yang P, Hsu HY, Chiou SS, Chao MC. Aust N Z J Psychiatry; 2007 Dec 28; 41(12):998-1004. PubMed ID: 17999272 [Abstract] [Full Text] [Related]
17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun 28; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
18. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Child Care Health Dev; 2006 Sep 28; 32(5):575-83. PubMed ID: 16919137 [Abstract] [Full Text] [Related]
19. [The evaluation of the effects of pharmacological treatment of children with attention deficit hyperactivity disorder]. Roselló B, Amado L, Presentación MJ. Rev Neurol; 1999 Feb 28; 28 Suppl 2():S177-82. PubMed ID: 10778510 [Abstract] [Full Text] [Related]
20. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)]. Stasik D, Tucha O, Tucha L, Walitza S, Lange KW. Psychiatr Pol; 2009 Feb 28; 43(2):183-92. PubMed ID: 19697788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]